[2P0101-26] ポスター発表

[2P0101-26-03] Evaluation of Intradermal Injection System (Terumo) for the Live Attenuated Vaccine, centrin-deficient Leishmania major (LmCen^-/-), against Leishmaniasis

○Farzaneh Valanezhad^1,2,3, Jalal Alshaweesh⁴, Shara Bakytbek^1,2,3, Sakiko Shimizu⁵, Ryo Tanaka⁵, Yoichiro Iwase⁵, Risa Nakamura^1,2,3, Greg Matlashewski⁶, Sreenivas Gannavaram⁷, Hira Nakhasi⁷, Abhay Satoskar⁸, Shinjiro Hamano^1,2,3 (1. Department of Parasitology, Institute of Tropical Medicine (NEKKEN)), The Joint Usage/Research Center on Tropical Disease, Nagasaki University., 2. Graduate School of Biomedical Sciences, Nagasaki University., 3. The Vaccine Research and Development Center, DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University., 4. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo., 5. TERUMO Corporation, Medical Care Solutions Company, Pharmaceutical Solutions Division, R&D., 6. Department of Microbiology and Immunology, McGill University., 7. Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA., 8. Department of Pathology, The Ohio State University.)

キーワード：

Leishmania major、Live attenuated vaccine、Immune response、Cytokine production、TERUMO Needle、Intradermal vaccination

閲覧にはパスワードが必要です